Beth A. Drolet, MD

Professor (Dermatology & Pediatrics)
Vice Chair, Department of Dermatology
Director, Birthmarks and Vascular Anomalies Center

Introduction

Dr. Beth Ann Drolet is a Professor of Dermatology and Pediatrics and Vice Chair of the Department of Dermatology at the Medical College of Wisconsin. She is a board certified dermatologist and a fellowship trained pediatric dermatologist. Her pediatric dermatology clinical practice has been with Children’s Hospital of Wisconsin since 1995, where she is currently both the Clinical Vice President of Ambulatory Services and Medical Director of Birthmarks and Vascular Anomalies. She is a founding member of board of directors of the PHACE Syndrome Community. Dr. Drolet is a graduate of Loyola University of Chicago, Stritch School of Medicine and completed her Residency as well as a Pediatric Dermatology Fellowship at the Medical College of Wisconsin.

Beth A. Drolet, MD
Beth A. Drolet, MD

In 2004, she established the Birthmarks and Vascular Anomalies Center at Children’s Hospital of Wisconsin. This unique interdisciplinary team includes ten pediatric specialties which provide comprehensive care for over fifteen hundred patients with rare, complex, and multi-system vascular anomalies. The center has attained national recognition with greater than 50% of patients traveling from outside Southeastern Wisconsin.

Dr. Drolet has a special interest in birthmarks, PHACE syndrome and infantile hemangiomas and has created a collaborative research infrastructure to improve management of infants with hemangiomas and vascular anomalies. She is a founding member and past president of the Hemangioma Investigator Group (HIG). HIG is the first multi-institutional research consortium in the field of pediatric dermatology and consists of a network of investigators at twelve institutions. She is the principal investigator on several large-scale NIH-funded research projects that have been designed to determine the best and safest treatment plans for these conditions. Dr. Drolet’s research team has also established and maintained international registries and bio-banks for patients with rare vascular anomalies. These successful studies and registries provide rich data and have resulted in many peer-reviewed publications that have defined phenotypes, diagnostic criteria, and long-term outcomes. In the last five years, the team has published thirty-two papers on the subject of rare vascular disorders, with more than sixty unique investigators from more than twenty institutions.

Dr. Drolet is a strong advocate for patients and families; she is committed to provide compassionate, timely care for children with skin disease and to develop an innovative research center that will bring new knowledge and ultimately provide more effective care for her patients.

Areas of Expertise

  • General Pediatric Dermatology
  • Birthmarks
  • Infantile Hemangiomas
  • Laser Surgery
  • PHACE Syndrome
  • Vascular Tumors & Birthmarks

Board Certifications

  • Dermatology, Pediatric Dermatology

Patient Ages Seen

  • Infant
  • Child
  • Adolescent

Languages Spoken

  • English

Education / Training

  • Doctor of Medicine – Loyola University of Chicago, Stritch School of Medicine – Maywood, IL (1991)
  • Residency – Medical College of Wisconsin – Milwaukee (1992-1995)
  • Fellowship in Pediatric Dermatology – Medical College of Wisconsin Affiliated Hospitals – Milwaukee (1995-1996)
  • Internship – University of Colorado Hospital – Denver (1991-1992)

Publications

In the News

Dermatology Researchers to Participate in National Study on Treatment of Infantile Hemangiomas

02/15/2017  |  Comments Off on Dermatology Researchers to Participate in National Study on Treatment of Infantile Hemangiomas

Dr. Beth Drolet Accepts New CHW Leadership Role

04/16/2015  |  Comments Off on Dr. Beth Drolet Accepts New CHW Leadership Role

Effective February 15, 2015, Dr. Beth Drolet joined Children's Hospital of Wisconsin (CHW) administration as Chief Experience Officer (CXO).  The CXO... more

Dr. Drolet Appointed President of SPD

10/22/2014  |  Comments Off on Dr. Drolet Appointed President of SPD

Please join us in celebrating Beth A. Drolet, MD’s appointment to President of the Society for Pediatric Dermatology (SPD). She... more

Dr. Drolet ‘Thought Leader’ for Pediatric Trials Network

04/01/2014  |  Comments Off on Dr. Drolet ‘Thought Leader’ for Pediatric Trials Network

Pediatric Trials Network Subcontract: Pediatric Thought Leader for Timolol in the “Pharmacokinetics of Understudied Drugs Administered to Children per Standard... more

CRI Pilot Innovative Research Award: A Mobile App for Adverse Event Reporting in the Treatment of Infantile Hemangiomas

04/01/2014  |  Comments Off on CRI Pilot Innovative Research Award: A Mobile App for Adverse Event Reporting in the Treatment of Infantile Hemangiomas

Dr. Beth Drolet (principal investigator) and Dr. Kristen Holland (co-principal investigator) received a one-year award in the amount of $33,252... more

New Faculty Leadership Roles

04/01/2014  |  Comments Off on New Faculty Leadership Roles

Drs. Drolet, Holland, Siegel, Galbraith, and Hwang have been appointed new leadership roles. ... more